AstraZeneca Pharma India Limited announced that it has received a Show Cause Notice from the National Pharmaceutical Pricing Authority (NPPA) on September 11, 2025, regarding alleged overcharging for batches of 'Symbicort Turbuhaler' Inhalation Powder. The NPPA claims that the company marketed or manufactured these products at prices exceeding the notified ceiling price between April 2016 and July 2025.
The NPPA has granted AstraZeneca Pharma India 30 days to respond to the allegations, which the company disputes. The notice alleges overcharging for 'Symbicort Turbuhaler' Inhalation Powder, 60 Doses each.
| Sl. No. | Particulars | Details |
|---|---|---|
| 1. | Name of the opposing party | National Pharmaceutical Pricing Authority (NPPA) |
| 2. | Brief details of dispute/litigation | NPPA, in its show cause notice dated September 11, 2025, has alleged that the Company has overcharged for batches of 'Symbicort Turbuhaler' Inhalation Powder, 60 Doses each, by marketing or manufacturing them at prices above the notified ceiling price subsequent to the relevant price notifications issued for the period from April 2016 to July 2025. The NPPA has given the Company 30 days to submit its response to these allegations. |
| 3. | Court/tribunal/agency where the litigation is filed | Not Applicable |
| 4. | Expected financial implications, if any, due to compensation, penalty etc. | The expected overall financial implication cannot be determined at this stage. The quantum of implication as per the notice is Rs. 60,49,79,385/- (Rupees Sixty Crore Forty Nine Lakh Seventy Nine Thousand Three Hundred and Eighty Five only) plus interest, which the Company disputes. |
| 5. | Quantum of claims, if any | Rs. 60,49,79,385/- (Rupees Sixty Crore Forty Nine Lakh Seventy Nine Thousand Three Hundred and Eighty Five only) plus interest, which the Company disputes. |
The NPPA's claim amounts to ₹60.49 Crore plus interest, which AstraZeneca disputes. The company is currently assessing the financial implications and will respond to the notice within the stipulated 30-day period.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
